Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; high potent products; and other products for oncology. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Revenue projections:

Revenue projections for GRANULES
Revenue projections for GRANULES

Investors may be wary of GRANULES as its revenues are expected to fall below the prior year's levels. A revenue decrease often leads to concerns about profitability, as it is likely to affect the company's bottom line, prompting investors to take a more cautious approach.

Financial Ratios:

currentRatio 1.277000
forwardPE 19.347483
debtToEquity 45.369000
earningsGrowth 0.342000
revenueGrowth 0.342000
grossMargins 0.612870
operatingMargins 0.158990
trailingEps 21.150000
forwardEps 0.000000

GRANULES's current ratio, being 1.277, means the company is well-positioned to meet its short-term debt obligations. This reflects GRANULES's strong liquidity, as its cash reserves and current assets provide more than enough coverage for its immediate liabilities.
Granules India Limited's Forward PE being in a good range indicates the stock is priced well relative to its earnings. It is not overvalued, leaving space for future growth, making it an appealing option for investors interested in long-term value appreciation.
With positive earnings and revenue growth, GRANULES is on a path to expand its business. This strong financial performance suggests the company will continue to grow, as increasing profits and revenue highlight a healthy outlook.

Price projections:

Price projections for GRANULES
Price projections for GRANULES

The present price of GRANULES in relation to its projections indicates a lack of clear risks or opportunities. This balanced situation suggests that investors may find it prudent to wait for further signals before making significant moves in the stock.

Recommendation changes over time:

Recommendations trend for GRANULES
Recommendations trend for GRANULES


With analysts showing a buy bias for GRANULES, investors may be more inclined to see the stock as an attractive investment. The favorable outlook could spur increased interest, positioning GRANULES as a safe and profitable place for investors to allocate their funds and seek growth.